Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: Apparent immunohistochemical false-positives do not get the message

Raymund R. Tubbs, J. D. Pettay, P. C. Roche, M. H. Stoler, R. B. Jenkins, T. M. Grogan

Research output: Contribution to journalArticlepeer-review

333 Scopus citations

Fingerprint

Dive into the research topics of 'Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: Apparent immunohistochemical false-positives do not get the message'. Together they form a unique fingerprint.

Medicine & Life Sciences